Matrix metalloproteinases and the immune response

Clinical and Applied Immunology Reviews

Volumn 4, Issue 5, 2004, Pages 295-319

  Szabo, Kristina A ^a   Ablin, Richard J ^b   Singh, Gurmit ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Tetragenex Pharmaceuticals Inc   (United States)

Author keywords

Host Response; Immune Cells; Inflammation; Martix metalloproteinases

Indexed keywords

COLONY STIMULATING FACTOR; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; DIGESTIVE SYSTEM INFLAMMATION; EMPHYSEMA; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TISSUE REPAIR; WOUND HEALING;

EID: 3242776237     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2004.02.001     Document Type: Review

References (224)

1. Nagase H. Woessner J.F.Jr. Matrix metalloproteinases J Biol Chem 274 1999 21491-21494
2. Bini A. Itoh Y. Kudryk B.J. Nagase H. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond Biochemistry 35 1996 13056-13063
3. Patterson B.C. Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/Type IV collagenase (MMP-9) J Biol Chem 272 1997 28823-28825
4. Cornelius L.A. Nehring L.C. Harding E. Bolanowski M. Welgus H.G. Kobayashi D.K. et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization J Immunol 161 1998 6845-6852
5. 2-terminal sequences of late-stage digest fragments Biochemistry 38 1999 13928-13936
6. Bergers G. Coussens L.M. Extrinsic regulators of epithelial tumour progression: metalloproteinases Curr Opin Genet Dev 10 2000 120-127
7. Hiller O. Lichte A. Oberpichler A. Kocourek A. Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type-1 matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII J Biol Chem 275 2000 33008-33013
8. McQuibban G.A. Gong J.H. Tam E.M. McCulloch C.A. Clark-Lewis I. Overall C.M. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3 Science 289 2000 1202-1206
9. Noë V. Fingleton B. Jacobs K. Crawford H.C. Vermeulen S. Steelant W. et al. Release of an invasion promotor E-cadherin fragment by matrilysin and stromelysin-1 J Cell Sci 114 2001 111-118
10. McCawley L.J. Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13 2001 534-540
11. Goetzl E. Banda M.J. Leppert D. Matrix metalloproteinases in immunity J Immunol 156 1996 1-4
12. Leppert D. Lindberg R.L. Kappos L. Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Res Brain Res Rev 36 2001 249-257
13. Coussens L.M. Fingleton B. Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387-2392
14. Woessner Jr. J.F. MMPs and TIMPs-an historical perspective Mol Biotechnol 22 2002 33-49
15. Borkakoti N. Structural studies of matrix metalloproteinases J Mol Med 78 2000 261-268
16. Nelson A.R. Fingleton B. Rothenberg M.L. Matrisian L.M. Matrix metalloproteinases: biologic activity and clinical implications J Clin Oncol 18 2000 1135-1149
17. Westermarck J. Kähäri V. Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 1999 781-792
18. Stetler-Stevenson W.G. Yu A.E. Proteases in invasion: matrix metalloproteinases Semin Cancer Biol 11 2001 143-152
19. Hoekstra R. Eskens F.A. Verweij E. Matrix metalloproteinase inhibitors: current developments and future perspectives Oncologist 6 2001 415-427
20. Hernandez-Barrantes S. Bernardo M. Toth M. Fridman R. Regulation of membrane type-matrix metalloproteinases Semin Cancer Biol 12 2002 131-138
21. Mauviel A. Cytokine regulation of metalloproteinase gene expression J Cell Biochem 53 1993 288-295
22. Madlener M. Mauch C. Conca W. Brauchle M. Parks W.C. Werner S. Regulation of the expression of stromelysin-2 by growth factors in keritanocytes: implications for normal and impaired wound healing Biochem J 320 1996 659-664
23. Fini M.E. Cook J.R. Mohan R. Regulation of MMP gene expression Parks W.C. Mecham R.P. Matrix metalloproteinases 1998 299-356 Academic Press San Diego, CA
24. Frisch S.M. Ruley H.E. Transcription from the stromelysin promotor is induced by interleukin-1 and repressed by dexamethasone J Biol Chem 262 1987 16300-16304
25. Kerr L.D. Miller D.B. Martrisian L.M. TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence Cell 61 1990 267-278
26. Lafyatis R. Kim S.J. Angel P. Roberts A.B. Sporn M.B. Karin M. et al. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site Mol Endocrinol 4 1990 973-980
27. Nicholson R.C. Mader S. Nagpal S. Leid M. Rochette-Egly C. Chambon P. Negative regulation of the rat stromelysin gene promotor by retinoic acid is mediated by an AP1 binding site EMBO J 9 1990 4443-4454
28. Delany A.M. Brinckerhoff C.E. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts J Cell Biochem 50 1992 400-410
29. Springman E.B. Angleton E.L. Birkedal-Hansen H. Van Wart H.E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation Proc Natl Acad Sci USA 87 1990 364-368
30. Morgunova E. Tuuttila A. Bergmann U. Isupov M. Lindqvist Y. Schneider G. et al. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed Science 284 1999 1667-1670
31. Cury J.D. Campbell E.J. Lazarus C.J. Albin R.J. Welgus H.G. Selective up-regulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts J Immunol 141 1988 4306-4312
32. Welgus H.G. Campbell E.J. Cury J.D. Eisen A.Z. Senior R.M. Wilhelm S.M. et al. Neutral metalloproteinases produced by human alveolar mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development J Clin Invest 86 1990 1496-1502
33. Campbell E.J. Cury J.D. Shapiro S.D. Goldberg G.I. Welgus H.G. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases J Immunol 146 1991 1286-1293
34. Busiek D.F. Ross F.P. McDonnell S. Murphy G. Matrisian L.M. Welgus H.G. The matrix metalloproteinase matrilysin (PUMP) is expressed in developing human mononuclear phagocytes J Biol Chem 267 1992 9087-9092
35. Shapiro S.D. Kobayashi D.K. Ley T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages J Biol Chem 268 1993 23824-23829
36. Shapiro S.D. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease Am J Respir Crit Care Med 150 1994 S160-S164
37. Xie B. Dong Z. Fidler I.J. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages J Immunol 152 1994 3637-3644
38. Belaaouaj A. Shipley J.M. Kobayashi D.K. Zimonjic D.B. Popescu N. Silverman G.A. et al. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression J Biol Chem 270 1995 14568-14575
39. Kumar R. Dong Z. Fidler I.J. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor J Immunol 157 1996 5104-5111
40. Chizzolini C. Rezzonico R. De Luca C. Burger D. Dayer J.M. Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes J Immunol 164 2000 5952-5960
41. Montgomery A.M. Sabzevari H. Reisfeld R.A. Production and regulation of gelatinase B by human T-cells Biochim Biophys Acta 1176 1993 265-268
42. Zhou H. Bernhard E.J. Fox F.E. Billings P.C. Induction of metalloproteinase activity in human T-lymphocytes Biochim Biophys Acta 1177 1993 174-178
43. Leppert D. Waubant E. Galardy R. Bunnett N.W. Hauser S.L. T cell gelatinases mediate basement membrane transmigration in vitro J Immunol 154 1995 4379-4389
44. Weiss S.J. Tissue destruction by neutrophils N Engl J Med 320 1989 365-376
45. Tschesche H. Groeger C. Wenzel H.R. Enzymatic fragment substitution as a tool in protein design Biomed Biochim Acta 50 1991 S175-S180
46. Sorsa T. Ding Y. Salo T. Lauhio A. Teronen O. Ingman T. et al. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases Ann N Y Acad Sci 732 1994 112-131
47. Opdenakker G. Van den Steen P.E. Dubois B. Nelissen I. Van Coillie E. Masure S. et al. Gelatinase B functions as regulator and effector in leukocyte biology J Leukoc Biol 69 2001 851-859
48. Schwartz J.D. Monea S. Marcus S.G. Patel S. Eng K. Galloway A.C. et al. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2 J Surg Res 76 1998 79-85
49. Lacraz S. Isler P. Vey E. Welgus H.G. Dayer J.M. Direct contact beween T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression J Biol Chem 269 1994 22027-22033
50. Aoudjit F. Potworowski E.F. St-Pierre Y. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1 J Immunol 160 1998 2967-2973
51. Baram D. Vaday G.G. Salamon P. Drucker I. Hershkoviz R. Mekori Y.A. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha J Immunol 167 2001 4008-4016
52. Bhattacharyya S.P. Drucker I. Reshef T. Kirshenbaum A.S. Metcalfe D.D. Mekori Y.A. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact J Leukoc Biol 63 1998 337-341
53. Burger D. Rezzonico R. Li J.M. Modoux C. Pierce R.A. Welgus H.G. et al. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines Arthritis Rheum 41 1998 1748-1759
54. Zhang J.H. Ferrante A. Arrigo A.P. Dayer J.M. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes J Immunol 148 1992 177-181
55. Malik N. Greenfield B.W. Wahl A.F. Kiener P.A. Activation of human monocytes through CD40 induces matrix metalloproteinases J Immunol 156 1996 3952-3960
56. Leppert D. Hauser S.L. Kishiyama J.L. An S. Zeng L. Goetzl E.J. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids FASEB J 9 1995 1473-1481
57. Kayagaki N. Kawasaki A. Ebata T. Ohmoto H. Ikeda S. Inoue S. et al. Metalloproteinase-mediated release of human Fas ligand J Exp Med 182 1995 1777-1783
58. Gearing A.J. Beckett P. Christodoulou M. Churchill M. Clements J. Davidson A.H. et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases Nature 370 1994 555-557
59. Chandler S. Cossins J. Lury J. Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein Biochem Biophys Res Commun 228 1996 421-429
60. Amour A. Slocombe P.M. Webster A. Butler M. Knight C.G. Smith B.J. et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3 FEBS Lett 435 1998 39-44
61. Ito A. Mukaiyama A. Itoh Y. Nagase H. Thogersen I.B. Enghild J.J. et al. Degradation of interleukin 1 beta by matix metalloproteinases J Biol Chem 271 1996 14657-14660
62. Arend W.P. Dayer J.M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis Arthritis Rheum 33 1990 305-315
63. Taub D.D. Oppenheim J.J. Chemokines, inflammation and the immune system Ther Immunol 1 1994 229-246
64. Unemori E.N. Hibbs M.S. Amento E.P. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines J Clin Invest 88 1991 1656
65. Hanemaaijer R. Sorsa T. Konttinen Y.T. Ding Y. Sutinen M. Visser H. et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells J Biol Chem 272 1997 31504-31509
66. Johnatty R.N. Taub D.D. Reeder S.P. Turcovski-Corrales S.M. Cottam D.W. Stephenson T.J. et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes J Immunol 158 1997 2327-2333
67. Leber T.M. Balkwill F.R. Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF) Br J Cancer 78 1998 724-732
68. Vaday G.G. Hershkoviz R. Rahat M.A. Lahat N. Cahalon L. Lider O. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis J Leukoc Biol 68 2000 737-747
69. Vaday G.G. Schor H. Rahat M.A. Lahat N. Lider O. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes J Leukoc Biol 69 2001 613-621
70. Robinson S.C. Scott K.A. Balkwill F.R. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha Eur J Immunol 32 2002 404-412
71. Sarén P. Welgus H.G. Kovanen P.T. TNF-alpha and IL-1 beta selectively induce expression of 92-kDa gelatinase by human macrophages J Immunol 157 1996 4159-4165
72. Jung H.C. Eckmann L. Yang S.K. Panja A. Fierer J. Morzycka-Wroblewska E. et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion J Clin Invest 95 1995 55-65
73. Romanic A.M. Madri J.A. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent J Cell Biol 125 1994 1165-1178
74. Xia M. Sreedharan S.P. Dazin P. Damsky C.H. Goetzl E.J. Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane J Cell Biochem 61 1996 452-458
75. Marsh C.B. Pomerantz R.P. Parker J.M. Winnard A.V. Mazzaferri E.L. Moldovan N. et al. Regulation of monocyte survival in vitro by deposited IgG: role of macrophage colony-stimulating factor J Immunol 162 1999 6217-6225
76. Akagawa K.S. Kamoshita K. Tokunaga T. Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages J Immunol 141 1988 3383-3390
77. Held T.K. Mielke M.E. Unger M. Trautmann M. Cross A.S. Kinetics and dose dependence of macrophage colony-stimulating factor-induced proliferation and activation of murine mononuclear phagocytes in situ: differences between lungs, liver and spleen J Interferon Cytokine Res 16 1996 159-168
78. Stanley E.R. Berg K.L. Einstein D.B. Lee P.S. Pixley F.J. Wang Y. et al. Biology and activation of colony-stimulating factor-1 Mol Reprod Dev 46 1997 4-10
79. Hashimoto S. Suzuki T. Dong H.Y. Yamazaki N. Matsushima K. Serial analysis of gene expression in human monocytes and macrophages Blood 94 1999 837-844
80. Zhang Y. McCluskey K. Fujii K. Wahl L.M. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and independent mechanisms J Immunol 161 1998 3071-3076
81. Fiore E. Fusco C. Romero P. Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity Oncogene 21 2002 5213-5223
82. Peschon J.J. Slack J.L. Reddy P. Stocking K.L. Sunnarborg S.W. Lee D.C. et al. An essential role for ectodomain shedding in mammalian development Science 282 1998 1281-1284
83. Hafezi-Moghadam A. Thomas K.L. Prorock A.J. Huo Y. Ley K. L-selectin shedding regulates leukocyte recruitment J Exp Med 193 2001 863-872
84. Perl A.K. Wilgenbus P. Dahl U. Semb H. Christofori G. A casual role for E-cadherin in the translation from adenocarcinoma to carcinoma Nature 392 1998 190-193
85. Gu B. Bendall L.J. Wiley J.S. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteinases Blood 92 1998 946-951
86. Okamoto I. Kawano Y. Tsuiki H. Sasaki J. Nakao M. Matsumoto M. et al. CD44 cleavage induced by a membrane-associated metalloproteinase plays a critical role in tumor cell migration Oncogene 18 1999 1435-1446
87. McGeehan G.M. Becherer J.D. Bast R.C. Boyer C.M. Champion B. Connolly K.M. et al. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor Nature 370 1994 558-561
88. Shapiro S.D. Campbell E.J. Kobayashi D.K. Welgus H.G. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma J Clin Invest 86 1990 1204-1210
89. Wahl L.M. Corcoran M.E. Mergenhagen S.E. Finbloom D.S. Inhibition of phospholipase activity in human monocytes by IFN-gamma blocks endogenous prostaglandin E2-dependent collagenase production J Immunol 144 1990 3518-3522
90. Woessner Jr. J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5 1991 2145-2154
91. Corcoran M.L. Stetler-Stevenson W.G. Brown P.D. Wahl L.M. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes J Biol Chem 267 1992 515-519
92. Lacraz S. Nicod L. Galve-de Rochemonteix B. Baumberger C. Dayer J.M. Welgus H.G. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4 J Clin Invest 90 1992 382-388
93. Mertz P.M. DeWitt D.L. Stetler-Stevenson W.G. Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production J Biol Chem 269 1994 21322-21329
94. Lacraz S. Nicod L. Chicheportiche R. Welgus H.G. Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes J Clin Invest 96 1995 2304-2310
95. Sica A. Saccani A. Borsatti A. Power C.A. Wells T.N. Luini W. et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes J Exp Med 185 1997 969-974
96. Weber C. Draude G. Weber K.S. Wubert J. Lorenz R.L. Weber P.C. Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions Atherosclerosis 145 1999 115-123
97. Ismair M.G. Ries C. Lottspeich F. Zang C. Kolb H.J. Petrides P.E. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1 Leukemia 12 1998 1136-1143
98. Liu Z. Shipley J.M. Vu T.H. Zhou X. Diaz L.A. Werb Z. et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid J Exp Med 188 1998 475-482
99. Leppert D. Waubant E. Burk M.R. Oksenberg J.R. Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis Ann Neurol 40 1996 846-852
100. Xia M. Leppert D. Hauser S.L. Sneedharan S.P. Nelson P.J. Krensky A.M. et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane J Immunol 156 1996 160-167
101. Pluznik D.H. Fridman R. Reich R. Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of myelomonocytic cells during differentiation into macrophages Exp Hematol 20 1992 57-63
102. López-Boado Y.S. Wilson C.L. Hooper L.V. Gordon J.I. Hultgren S.J. Parks W.C. Bacterial exposure induces and activates matrilysin in mucosal epithelial cells J Cell Biol 148 2000 1305-1315
103. Parks W.C. Lopez-Boado Y.S. Wilson C.L. Matrilysin in epithelial repair and defense Chest 120 2001 36S-41S
104. Dunsmore S.E. Saarialho-Kere U.K. Roby J.D. Wilson C.L. Matrisian L.M. Welgus H.G. et al. Matrilysin expression and function in airway epithelium J Clin Invest 102 1998 1321-1331
105. Wilson C.L. Ouellette A.J. Satchell D.P. Ayabe T. López-Boada Y.S. Stratman J.L. et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense Science 286 1999 113-117
106. McQuibban G.A. Gong J.H. Wong J.P. Wallace J.L. Clark-Lewis I. Overall C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo Blood 100 2002 1160-1167
107. Schönbeck U. Mach F. Sukhova G.K. Murphy C. Bonnefoy J.Y. Fabunmi R.P. et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 81 1997 448-454
108. Kerr L.D. Olashaw N.E. Matrisian L.M. Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor and oncogene-induced transin RNA J Biol Chem 263 1988 16999-17005
109. Overall C.M. Wrana J.L. Sodek J. Transcriptional and post-transcriptional regulation of a 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts: Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression J Biol Chem 266 1991 14064-14071
110. Noble L.J. Donovan F. Igarashi T. Goussev S. Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events J Neurosci 22 2002 7526-7535
111. Lobmann R. Ambrosch A. Schultz G. Waldmann K. Schiweck S. Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients Diabetologia 45 2002 1011-1016
112. Mirastschijski U. Impola U. Jahkola T. Karlsmark T. Agren M.S. Saarialho-Kere U. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds Hum Pathol 33 2002 355-364
113. Pender S.L. Tickle S.P. Docherty A.J. Howie D. Wathen N.C. MacDonald T.T. A major role for matrix metalloproteinases in T cell injury in the gut J Immunol 158 1997 1582-1590
114. McCabe R.P. Secrist H. Botney M. Egan M. Peters M.G. Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients Clin Immunol Immunopathol 66 1993 52-58
115. Youngman K.R. Simon P.L. West G.A. Cominelli F. Rachmilewitz D. Klein J.S. et al. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells Gastroenterology 104 1993 749-758
116. Breese E.J. Michie C.A. Nicholls S.W. Murch S.H. Williams C.B. Domizio P. et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease Gastroenterology 106 1994 1455-1466
117. Braegger C.P. Nicholls S. Murch S.H. Stephens S. MacDonald T.T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation Lancet 339 1992 89-91
118. Murch S.H. Braegger C.P. Walker-Smith J.A. MacDonald T.T. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease Gut 34 1993 1705-1709
119. Pender S.L. Fell J.M. Chamow S.M. Ashkenazi A. MacDonald T.T. A p55 TNF receptor immunoadhesion prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production J Immunol 160 1998 4098-4103
120. Bailey C.J. Hembry R.M. Alexander A. Irving M.H. Grant M.E. Shuttleworth C.A. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine J Clin Pathol 47 1994 113-116
121. Salmela M.T. MacDonald T.T. Black D. Irvine B. Zhuma T. Saarialho-Kere U. et al. Upregulation of matrix metalloproteinases in a model of T cell mediated injury in the gut: analysis by gene array and in situ hybridisation Gut 51 2002 540-547
122. Sanes J.R. Extracellular matrix molecules that influence neural development Ann Rev Neurosci 12 1989 491-516
123. Sobel R.A. The extracellular matrix in multiple sclerosis lesions J Neuropathol Exp Neurol 57 1998 205-217
124. Lo E.H. Wang X. Cuzner M.L. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases J Neurosci Res 69 2002 1-9
125. Leppert D. Leib S.L. Grygar C. Miller K.M. Schaad U.B. Holländer G.A. Matrix metalloproteinase (MMP)-8 and and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae Clin Infect Dis 31 2000 80-84
126. Cuzner M.L. Opdenakker G. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system J Neuroimmunol 94 1999 1-14
127. Herron G.S. Banda M.J. Clark E.J. Gavrilovic J. Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells J Biol Chem 261 1986 2814-2818
128. Gottschall P.E. Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes J Neurochem 64 1995 1513-1520
129. Gottschall P.E. Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons Neuroimmunomodulation 3 1996 69-75
130. Oh L.Y. Larsen P.H. Krekoski C.A. Edwards D.R. Donovan F. Werb Z. et al. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes J Neurosci 19 1999 8464-8475
131. Zhuo M. Holtzman D.M. Li Y. Osaka H. DeMaro J. Jacquin M. et al. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation J Neurosci 20 2000 542-549
132. Wang X. Jung J. Asahi M. Chwang W. Russo L. Moskowitz M.A. et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury J Neurosci 20 2000 7037-7042
133. Romanic A.M. White R.F. Arleth A.J. Ohlstein E.H. Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size Stroke 29 1998 1020-1030
134. Rosenberg G.A. Estrada E.Y. Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain Stroke 29 1998 2189-2195
135. Asahi M. Asahi K. Jung J.C. del Zoppo G.J. Fini M.E. Lo E.H. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94 J Cereb Blood Flow Metab 20 2000 1681-1689
136. Jiang X. Namura S. Nagata I. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice Neurosci Lett 305 2001 41-44
137. Asahi M. Sumii T. Fini M.E. Itohara S. Lo E.H. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia Neuroreport 12 2001 3003-3007
138. Rosenberg G.A. Kornfeld M. Estrada E. Kelley R.O. Liotta L.A. Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase Brain Res 576 1992 203-207
139. Maeda A. Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis lesions J Neuropathol Exp Neurol 55 1996 300-309
140. Anthony D.C. Ferguson B. Matyzak M.K. Miller K.M. Esiri M.M. Perry V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke Neuropathol Appl Neurobiol 23 1997 406-415
141. Anthony D.C. Miller K.M. Fearn S. Townsend M.J. Openakker G. Wells G.M. et al. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat central nervous system (CNS) J Neuroimmunol 87 1998 62-72
142. Lichtinghagen R. Seifert T. Kracke A. Marckmann S. Wurster U. Heidenreich F. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis J Neuroimmunol 99 1999 19-26
143. Owen C.A. Campbell E.J. The cell biology of leukocyte-mediated proteolysis J Leukoc Biol 65 1999 137-150
144. Malipiero U.V. Frei K. Fontana A. Production of hemopoietic colony-stimulating factors by astrocytes J Immunol 144 1990 3816-3821
145. Bond M. Baker A. Newby A.C. Nuclear factor kappa B activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts Biochem Biophys Res Commun 264 1999 561-567
146. Hughes P.M. Wells G.M. Clements J.M. Gearing A.J. Redford E.J. Davies M. et al. Matrix metalloproteinase expression during experimental autoimmune neuritis Brain 121 1998 481-494
147. Gijbels K. Masure S. Carton H. Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders J Neuroimmunol 41 1992 29-34
148. Proost P. Van Damme J. Opdenakker G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein Biochem Biophys Res Commun 192 1993 1175-1181
149. Chandler S. Coates R. Gearing A. Lury J. Wells G. Bone E. Matrix metalloproteinases degrade myelin basic protein Neurosci Lett 201 1995 223-226
150. Russell R.E. Culpitt S.V. DeMatos C. Donnelly L. Smith M. Wiggins J. et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 26 2002 602-609
151. Nathan C.F. Secretory products of macrophages J Clin Invest 79 1987 319-326
152. Sibille Y. Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defence and injury Am Rev Respir Dis 141 1990 471-501
153. Lukacs N.W. Ward P.A. Inflammatory mediators, cytokines and adhesion molecules in pulmonary inflammation and injury Adv Immunol 62 1996 257-304
154. Ward P.A. Recruitment of inflammatory cells into lungs: roles of cytokines, adhesion molecules, and complement J Lab Clin Med 129 1997 400-404
155. Trask B.C. Malone M.J. Lum E.H. Welgus H.G. Crouch E.C. Shapiro S.D. Induction of macrophage matrix metalloproteinase biosynthesis by surfactant protein D J Biol Chem 276 2001 37846-37852
156. Shapiro S.D. Campbell E.J. Welgus H.G. Senior R.M. Elastin degradation by mononuclear phagocytes Ann N Y Acad Sci 624 1991 69-80
157. Shapiro S.D. Kobayashi D.K. Pentland A.P. Welgus H.G. Induction of macrophage metalloproteinases by extracellular matrix: Evidence for enzyme and substrate-specific responses involving prostaglandin-dependent mechanisms J Biol Chem 268 1993 8170-8175
158. Senior R.M. Connolly N.L. Cury J.D. Welgus H.G. Campbell E.J. Elastin degradation by human alveolar macrophages. A prominent role of metalloproteinase activity Am Rev Respir Dis 139 1989 1251-1256
159. Hautamaki R.D. Kobayashi D.K. Senior R.M. Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice Science 277 1997 2002-2004
160. Shipley J.M. Wesselschmidt R.L. Kobayashi D.K. Ley T.J. Shapiro S.D. Metalloproteinase is required for macrophage-mediated proteolysis and matrix invasion in mice Proc Natl Acad Sci USA 93 1996 3942-3946
161. Hunninghake G.W. Davidson J.M. Rennard S. Szapiel S. Gadek J.E. Crystal R.G. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema Science 212 1981 925-927
162. Hartzell W. Shapiro S.D. Macrophage elastase prevents Gemella morbillorum infection and improves outcome following murine bone marrow transplantation Chest 116 1999 31S-32S
163. Mautino G. Oliver N. Chanez P. Bousquet J. Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics Am J Respir Cell Mol Biol 17 1997 583-591
164. Ohno I. Ohtani H. Nitta Y. Suzuki J. Hoshi H. Honma M. et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation Am J Respir Cell Mol Biol 16 1997 212-219
165. Cataldo D.D. Tournoy K.G. Vermaelen K. Munaut C. Foidart J.M. Louis R. et al. Matrix metalloproteinase-9 deficiency impairs
166. Harris E.D. Rheumatiod arthritis. Pathophysiology and implication for therapy N Engl J Med 322 1990 1277-1289
167. Yanni G. Whelan A. Feighery C. Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis Ann Rheum Dis 53 1994 39-44
168. Mulherin D. Fitzgerald O. Bresnihan B. Synovial tissue macrophage populations and articular cartilage damage in rheumatoid arthritis Arthritis Rheum 39 1996 115-124
169. Tak P.P. Smeets T.J. Daha M.R. Kluin P.M. Meijers K.A. Brand R. et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activty Arthritis Rheum 40 1997 217-225
170. Ahrens D. Koch A.E. Pope R.M. Stein-Picarella M. Niedbala M.J. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis Arthritis Rheum 39 1996 1576-1587
171. Konttinen Y.T. Ainola M. Valleala H. Ma J. Ida H. Mandelin J. et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis Ann Rheum Dis 58 1999 691-697
172. Jackson C. Nguyen M. Arkell J. Sambrook P. Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis-targetting gelatinase A activation Inflamm Res 50 2001 183-186
173. Walsh D.A. Angiogenesis and arthritis Rheumatol 38 1999 103-112
174. Itoh T. Matsuda H. Tanioka M. Kuwabara K. Itohara S. Suzuki R. The role of matrix metalloproteinase-9 in antibody-induced arthritis J Immunol 169 2002 2643-2647
175. Cunnane G. Fitzgerald O. Hummel K.M. Synovial tissue protease gene expression and joint erosion in early rheumatoid arthritis Arthritis Rheum 44 2001 1744-1753
176. Yamanaka H. Makino K. Takizawa M. Nakamura H. Fujimoto N. Moriya H. et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium Lab Invest 80 2000 677-687
177. Matsuno H. Yudoh K. Watanabe Y. Nakazawa F. Aono H. Kimura T. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potntial to cleave membrane bound Fas ligand J Rheumatol 28 2001 22-28
178. Jovanovic D.V. Martel-Pelletier J. Di Battista J.A. Mineau F. Jolicoeur F.C. Benderdour M. et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatiod arthritis Arthritis Rheum 43 2000 1134-1144
179. Maini R.N. Taylor P.C. Anti-cytokine therapy for rheumatoid arthritis Annu Rev Med 51 2000 207-229
180. Koch A.E. Kunkel S.L. Harlow L.A. Johnson B. Evanoff H.L. Haires G.K. et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis J Clin Invest 90 1992 772-779
181. Koch A.E. Kunkel S.L. Harlow L.A. Mazarakis D.D. Haines G.K. Burdick M.D. et al. Macrophage inflammatory protein-alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis J Clin Invest 93 1994 921-928
182. Bernhagen J. Calandra T. Mitchell R.A. Martin S.B. Tracy K.J. Voelter W. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature 365 1993 756-759
183. Nishino T. Bernhagen J. Shiiki H. Calandra T. Dohi K. Bucala R. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland Mol Med 1 1995 781-788
184. Calandra T. Bernhagen J. Mitchell R.A. Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J Exp Med 179 1994 1895-1902
185. Onodera S. Kaneda K. Mizue Y. Koyama Y. Fujinaga M. Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis J Biol Chem 275 2000 444-450
186. Perlman H. Bradley K. Liu H. Cole S. Shamieyeh E. Smith R.C. et al. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts J Immunol 170 2003 838-845
187. Leek R.D. Harris A.L. Lewis C.E. Cytokine networks in solid human tumors: regulation of angiogenesis J Leukoc Biol 56 1994 423-435
188. Neville M.C. Medina D. Monks J. Hovey R.C. The mammary fat pad J Mammary Gland Biol Neoplasia 3 1998 109-116
189. Alexander C.M. Selvarajan S. Mudgett J. Werb Z. Stromelysin-1 regulates adipogenesis during mammary gland involution J Cell Biol 152 2001 693-703
190. Giannelli G. Fransvea E. Marinosci F. Bergamini C. Daniele A. Colucci S. et al. Gelatinase levels in male and female breast cancer Biochem Biophys Res Commun 292 2002 161-166
191. Atula S. Grenman R. Syrjanen S. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro Exp Cell Res 235 1997 180-187
192. Ohtani H. Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions Pathol Int 48 1998 1-9
193. Basset P. Okada A. Chenard M.P. Kannan R. Stoll I. Anglard P. et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications Matrix Biol 15 1997 535-541
194. Uria J.A. Stahle-Backdahl M. Seiki M. Fueyo A. Lopez-Otin C. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions Cancer Res 57 1997 4882-4888
195. Johnsen M. Lund L.R. Romer J. Almholt K. Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation Curr Opin Cell Biol 10 1998 667-671
196. Johansson N. Vaalamo M. Grenman S. Hietanen S. Klemi P. Saarialho-Kere U. et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas Am J Pathol 154 1999 469-480
197. Sheu B.-C. Hsu S.-M. Ho H.-N. Lien H.-C. Huang S.-C. Lin R.-H. A novel role of metalloproteinase in cancer-mediated immunosuppression Cancer Res 61 2001 237-242
198. Yu Q. Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis Genes Dev 14 2000 163-176
199. Gorelik L. Flavell R.A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells Nat Med 7 2001 1118-1122
200. Kataoka H. Uchino H. Iwamura T. Sseiki M. Nabeshima K. Koono M. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal framgent of α1-Proteinase inhibitor generated by matrix metalloproteinases Am J Pathol 154 1999 457-468
201. Göttlinger H.G. Rieber P. Gokel J.M. Lohe K.J. Riethmuller G. Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma Int J Cancer 35 1985 199-205
202. Kelly P.M. Davison R.S. Bliss E. McGee J.O. Macrophages in human breast disease: a quantitative immunohistochemical study Br J Cancer 57 1988 174-177
203. Leek R.D. Lewis C.E. Whitehouse R. Greenall M. Clarke J. Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma Cancer Res 56 1996 4625-4629
204. O'Sullivan C. Lewis C.E. Tumour-associated leukocytes: friends or foes in breast carcinoma J Pathol 172 1994 229-235
205. Normann S.J. Macrophage infiltration and tumor progression Cancer Metastasis Rev 4 1985 277-291
206. Ring P. Johansson K. Hoyhtya M. Rubin K. Lindmark G. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage Br J Cancer 76 1997 805-811
207. Jaalinoja J. Herva R. Korpela M. Hoyhtya M. Turpeenniemi-Hujanen T. Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms J Neurooncol 46 2000 81-90
208. Zuk J.A. Walker R.A. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast J Pathol 152 1987 275-285
209. Van Netten J.P. Ashmead B.J. Parker R.L. Thornton I.G. Fletcher C. Cavers D. et al. Macrophage-tumor cell associations: a factor in metastasis of breast cancer? J Leukoc Biol 54 1993 360-362
210. Turnock K. Bulmer J.N. Gray C. Phenotypic characterization of macrophage subpopulations and localization of factor XIII in the stromal cells of carcinomas Histochem J 22 1990 661-666
211. Mantovani A. Bottazzi B. Colotta F. Sozzani S. Ruco L. The origin and function of tumor-associated macrophages Immunol Today 13 1992 265-270
212. Van Netten J.P. George E.J. Ashmead B.J. Fletcher C. Thornton I.G. Coy P. Macrophage-tumor cell associations in breast cancer Lancet 342 1993 872-873
213. Graves D.T. Valent A.J. Monocyte chemotactic proteins from human tumor cells Biochem Pharmacol 41 1991 333-337
214. Fu Y.X. Cai J.P. Chin Y.H. Watson G.A. Lopez D.M. Regulation of leukocyte binding protein to endothelial tissues by tumor-derived granulocyte macrophage colony-stimulating factor (GM-CSF) Int J Cancer 50 1992 585-588
215. Stewart T. Tsai S.C. Grayson H. Henderson R. Opelz G. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation Lancet 346 1995 796-798
216. Sunderkotter C. Steinbrink K. Goebeler M. Bhardwaj R. Sorg C. Macrophages and angiogenesis J Leukoc Biol 55 1994 410-422
217. Leibovich S.J. Polverini P.J. Fong T.W. Harlow L.A. Koch A.E. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism Proc Natl Acad Sci USA 91 1994 4190-4194
218. Miles D.W. Happerfield L.C. Naylor M.S. Bobrow L.G. Rubens R.D. Balkwill F.R. Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue Int J Cancer 56 1994 777-782
219. Pusztai L. Clover L.M. Cooper K. Starkey P.M. Lewis C.E. McGee J.O. Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast Br J Cancer 70 1994 289-292
220. O'Reilly M.S. Boehm T. Shing Y. Fukai N. Vasios G. Lane W.S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277-285
221. Dong Z. Kumar R. Yang X. Fidler I.J. Macrophage-derived metalloproteinase is responsible for the generation of angiostatin in Lewis lung carcinoma Cell 88 1997 801-810
222. Lijnen H.R. Ugwu F. Bini A. Collen D. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3) Biochemistry 37 1998 4699-4702
223. Moss M.L. Jin S.L. Milla M.E. Bickett D.M. Burkhart W. Carter H.L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha Nature 385 1997 733-736
224. Whalen G.F. Solid tumours and wounds: transformed cells misunderstood as injured tissue? Lancet 336 1990 1489-1492